These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28988546)

  • 1. The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series.
    Carrigan N; Dysch L; Salkovskis PM
    Behav Cogn Psychother; 2018 Mar; 46(2):148-167. PubMed ID: 28988546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
    Harand C; Daniel F; Mondou A; Chevanne D; Creveuil C; Defer G
    Trials; 2019 Oct; 20(1):614. PubMed ID: 31665039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of telephone-administered cognitive-behavioral therapy on quality of life among patients with multiple sclerosis.
    Cosio D; Jin L; Siddique J; Mohr DC
    Ann Behav Med; 2011 Apr; 41(2):227-34. PubMed ID: 21069585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years.
    Tyrer P; Salkovskis P; Tyrer H; Wang D; Crawford MJ; Dupont S; Cooper S; Green J; Murphy D; Smith G; Bhogal S; Nourmand S; Lazarevic V; Loebenberg G; Evered R; Kings S; McNulty A; Lisseman-Stones Y; McAllister S; Kramo K; Nagar J; Reid S; Sanatinia R; Whittamore K; Walker G; Philip A; Warwick H; Byford S; Barrett B
    Health Technol Assess; 2017 Sep; 21(50):1-58. PubMed ID: 28877841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.
    Kiropoulos L; Kilpatrick T; Kalincik T; Churilov L; McDonald E; Wijeratne T; Threader J; Rozenblat V; O’Brien-Simpson N; Van Der Walt A; Taylor L
    Trials; 2020 Jan; 21(1):100. PubMed ID: 31959224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.
    Lincoln NB; Bradshaw LE; Constantinescu CS; Day F; Drummond AE; Fitzsimmons D; Harris S; Montgomery AA; das Nair R
    Health Technol Assess; 2020 Jan; 24(4):1-182. PubMed ID: 31934845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which cognitions and behaviours mediate the positive effect of cognitive behavioural therapy on fatigue in patients with multiple sclerosis?
    Knoop H; van Kessel K; Moss-Morris R
    Psychol Med; 2012 Jan; 42(1):205-13. PubMed ID: 21672300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study.
    Askey-Jones S; David AS; Silber E; Shaw P; Chalder T
    Behav Res Ther; 2013 Oct; 51(10):648-55. PubMed ID: 23916634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mindfulness based interventions in multiple sclerosis--a systematic review.
    Simpson R; Booth J; Lawrence M; Byrne S; Mair F; Mercer S
    BMC Neurol; 2014 Jan; 14():15. PubMed ID: 24438384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial.
    Tyrer P; Cooper S; Salkovskis P; Tyrer H; Crawford M; Byford S; Dupont S; Finnis S; Green J; McLaren E; Murphy D; Reid S; Smith G; Wang D; Warwick H; Petkova H; Barrett B
    Lancet; 2014 Jan; 383(9913):219-25. PubMed ID: 24139977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot randomized controlled trial.
    Siengsukon CF; Alshehri M; Williams C; Drerup M; Lynch S
    Mult Scler Relat Disord; 2020 May; 40():101958. PubMed ID: 32014809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and cognitive functions in early onset multiple sclerosis.
    Lanzillo R; Chiodi A; Carotenuto A; Magri V; Napolitano A; Liuzzi R; Costabile T; Rainone N; Freda MF; Valerio P; Brescia Morra V
    Eur J Paediatr Neurol; 2016 Jan; 20(1):158-63. PubMed ID: 26387071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of cognitive behavioral therapy on the quality of life of patients with inflammatory bowel disease: multi-center design and study protocol (KL!C- study).
    Bennebroek Evertsz' F; Bockting CL; Stokkers PC; Hinnen C; Sanderman R; Sprangers MA
    BMC Psychiatry; 2012 Dec; 12():227. PubMed ID: 23237076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does depression in multiple sclerosis mediate effects of cognitive functioning on quality of life?
    Crouch TA; Reas HE; Quach CM; Erickson TM
    Qual Life Res; 2022 Feb; 31(2):497-506. PubMed ID: 34228241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing individual and group intervention for psychological adjustment in people with multiple sclerosis: a feasibility randomised controlled trial.
    das Nair R; Kontou E; Smale K; Barker A; Lincoln NB
    Clin Rehabil; 2016 Dec; 30(12):1156-1164. PubMed ID: 26555330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis.
    Kiropoulos LA; Kilpatrick T; Holmes A; Threader J
    BMC Psychiatry; 2016 Dec; 16(1):435. PubMed ID: 27927175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behaviour therapy for distress in people with inflammatory bowel disease: A benchmarking study.
    Jordan C; Hayee B; Chalder T
    Clin Psychol Psychother; 2019 Jan; 26(1):14-23. PubMed ID: 30207003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of neurological impairment, depression, cognitive function and coping on quality of life of people with multiple sclerosis: A relative importance analysis.
    Fernández-Jiménez E; Arnett PA
    Mult Scler; 2015 Oct; 21(11):1468-72. PubMed ID: 25533298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping strategies and quality of life in Mexican multiple sclerosis patients: Physical, psychological and social factors relationship.
    Hernández-Ledesma AL; Rodríguez-Méndez AJ; Gallardo-Vidal LS; Trejo-Cruz G; García-Solís P; Dávila-Esquivel FJ
    Mult Scler Relat Disord; 2018 Oct; 25():122-127. PubMed ID: 30071505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.